関連する実験動画
Updated: Jan 13, 2026

13:42
Measurement of Antibody Effects on Cellular Function of Isolated Cardiomyocytes
Published on: March 8, 2013
12.2K
進行性拡張型心筋症における免疫吸着療法の成功:症例報告
Rendan Zhang1,2, Lvwen Ning1,2, Ying Liu1,2
1Department of Geriatrics, Shenzhen Longhua District Central Hospital, Shenzhen, Guang Dong, P.R. China.
Medicine
|January 10, 2026
まとめ
免疫吸着(IA)は、進行性で難治性の拡張型心筋症(DCM)の患者に有益である可能性があります。この症例では、IAが治療抵抗性のDCM患者の症状と心機能を改善しました。
科学分野:
- 循環器学
- 免疫学
背景:
- 拡張型心筋症(DCM)は心不全の主な原因です。
- 一部のDCM患者は標準治療に反応しません。
- 免疫吸着(IA)は自己抗体を除去するための実験的治療法です。
研究 の 目的:
- 進行性で治療抵抗性のDCMにおけるIAの潜在的な利点を示すこと。
- 重度のDCM患者におけるIAの症例提示。
主な方法:
- 医学的治療にもかかわらず症状が悪化している進行性DCM患者を対象としました。
- 患者は2回の免疫吸着(IA)セッションを受けました。
- IA後に高用量の静脈内免疫グロブリン(IVIG)を投与しました。
主要な成果:
- IAおよびIVIG投与後、患者の症状が改善しました。
- Pro-BNP値は著しく低下しました。
- 左室駆出率(LVEF)は22-24%から29.2%に増加しました。
結論:
- 免疫吸着は、難治性DCMの有益な補助療法となる可能性があります。
- IAは有望ですが、より大規模な研究でのさらなる調査が必要です。
- この症例は、重度の心不全に対する潜在的な新しい治療経路を強調しています。
関連する概念動画
Cardiomyopathy II: Dilated Cardiomyopathy
455
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
455
Cardiomyopathy V: Interprofessional Care
326
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
326
Cardiomyopathy III: Hypertrophic Cardiomyopathy
387
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
387
Cardiomyopathy IV: Restrictive Cardiomyopathy
439
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
439
Myocarditis III: Medical Management
168
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
168
Heart Failure Drugs: Inotropic Agents
1.2K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.2K

